Parexel Insights

Parexel names first Patient Ambassador

06.17.22 - 3 min - Cancer thriver and rare disease care partner Stacy Hurt is Parexel’s first Patient Ambassador and “secret weapon” to develop patient-centric clinical trials.

Mitigating FSP talent shortfalls through development

06.14.22 - 6 min - Clinical research lacks workers — but in FSP, we’re training the professionals we need

Adapting drug supply strategies to modern study models

06.01.22 - 4 min - As decentralized trials gain prevalence, clinical supply chains can flex to meet new needs.

Maintaining Data Integrity for Quality and Compliance – Essential Despite Pandemic Disruptions

05.16.22 - 4 min - Just because the COVID pandemic disrupted business operations, the importance of data integrity in manufacturing has not diminished. Accurate data is the foundation of product quality. How can sponsors reconcile the adaptations they made during the emergency with data quality assurance and regulatory expectations for compliance?

New FDA Guidance Addresses the Need for Data-Generation Strategies Across the Drug Development Lifecycle

05.10.22 - 6 min - Over the past decade, there has been a proliferation of real-world data (RWD) sources that sponsors can use to generate real-world evidence (RWE) for a wide range of purposes across the product development lifecycle. In addition to traditional claims and administrative data, they now have access to even higher-quality patient-level and regulatory-grade data generated by healthcare systems.

We are always available for a conversation.

*